Literature DB >> 2123885

Quantitation of antibody reactivity to human immunodeficiency virus (type 1) proteins and glycoproteins on Western immunoblots by reflectance densitometry.

C T Hardy1, T A Damrow, G E Kenny.   

Abstract

The human serum antibody response to polypeptides of human immunodeficiency virus type 1 (HIV-1) was quantitated by reflectance densitometry of Western immunoblots by using two commercially available blotting systems. In one system, human antibodies were detected by an avidin-biotin method using peroxidase as the label, and in the other, human antibodies were detected by peroxidase-labeled conjugate against human immunoglobulins. When staining intensity was plotted against the log of the serum dilution, a shallow slope was evident, with a 50% change in staining intensity requiring as much as a 100-fold change in antibody content. The linear range of the staining intensity curves was frequently found in serum dilutions of 1:2,500 to 1:1,000,000, and a plateau was often observed at high antibody concentrations (1:80 to 1:640). When replicate strips were tested, staining intensities varied by +/- 7 to 37%. Antibodies to p24gag and gp160env were readily detectable in several sera diluted 1:1,000,000, a result seen with both blotting systems. If Western blotting were to be used to observe increase or decreases in levels of antibodies to various polypeptides, several widely spaced serum dilutions would need to be tested.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123885      PMCID: PMC268220          DOI: 10.1128/jcm.28.11.2534-2538.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status.

Authors:  G Schmidt; K Amiraian; H Frey; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection.

Authors:  J C Ulstrup; K Skaug; K J Figenschau; I Orstavik; J N Bruun; G Petersen
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

3.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

4.  Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.

Authors:  C T Fang; F Darr; S Kleinman; R H Wehling; R Y Dodd
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

5.  Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.

Authors:  D G Schiavini; J M Puel; S A Averous; J A Bazex
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

Authors:  J W Ward; A J Grindon; P M Feorino; C Schable; M Parvin; J R Allen
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

7.  Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.

Authors:  R W Hankins; F L Black
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Quantification of specific antibody response to Cryptosporidium antigens by laser densitometry.

Authors:  B L Ungar; T E Nash
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

10.  Antibody response in primary human immunodeficiency virus infection.

Authors:  H Gaines; M von Sydow; A Sönnerborg; J Albert; J Czajkowski; P O Pehrson; F Chiodi; L Moberg; E M Fenyö; B Asjö
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.